ID   RhRKM-P4
AC   CVCL_Y585
SY   RHRKMP-4; RHRKMP4
DR   Wikidata; Q54950394
RX   PubMed=11306473;
RX   PubMed=12239174;
RX   PubMed=23665679;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
RX   PubMed=11306473;
RA   Cripe T.P., Dunphy E.J., Holub A.D., Saini A., Vasi N.H.,
RA   Mahller Y.Y., Collins M.H., Snyder J.D., Krasnykh V., Curiel D.T.,
RA   Wickham T.J., DeGregori J.V., Bergelson J.M., Currier M.A.;
RT   "Fiber knob modifications overcome low, heterogeneous expression of
RT   the coxsackievirus-adenovirus receptor that limits adenovirus gene
RT   transfer and oncolysis for human rhabdomyosarcoma cells.";
RL   Cancer Res. 61:2953-2960(2001).
//
RX   PubMed=12239174; DOI=10.1182/blood-2002-01-0031;
RA   Libura J.J., Drukala J., Majka M., Tomescu O., Navenot J.-M., Kucia M.,
RA   Marquez L., Peiper S.C., Barr F.G., Janowska-Wieczorek A.,
RA   Ratajczak M.Z.;
RT   "CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and
RT   regulates locomotion, chemotaxis, and adhesion.";
RL   Blood 100:2597-2606(2002).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//